NCT02826902 is a NA clinical trial of propofol and remifentanil in Short Stature, sponsored by Yonsei University.

Who is sponsoring NCT02826902?

NCT02826902 is sponsored by Yonsei University.

What drugs are being tested in NCT02826902?

Interventions in NCT02826902: propofol and remifentanil, desflurane and remifentanil.

What condition does NCT02826902 study?

NCT02826902 studies Short Stature, Osteoarthritis.

Is NCT02826902 still recruiting?

NCT02826902 is currently completed. Last updated 16 March 2020.

Last reviewed 2020-03-16 · How we verify

NCT02826902

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial

Completed NA Last updated 16 March 2020

What this trial tests

NA trial testing propofol and remifentanil in Short Stature in 76 participants. Completed in 9 November 2019.

Timeline

27 September 2016

Primary endpoint
9 November 2019

9 November 2019

Quick facts

Lead sponsor	Yonsei University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	76
Start date	27 September 2016
Primary completion	9 November 2019
Estimated completion	9 November 2019
Sites	1 location across South Korea

Drugs / interventions tested

propofol and remifentanil — full drug profile →
desflurane and remifentanil — full drug profile →

Conditions studied

Short Stature — all drugs for Short Stature →
Osteoarthritis — all drugs for Osteoarthritis →

Sponsor

Yonsei University

Who can join

19 and older, any sex, with Short Stature or Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The effect of total intravenous anesthesia (TIVA) versus inhalational anesthesia on the quality of recovery from surgery has been reported in several different types of operations. The Quality of Recovery 40 (QoR-40) questionnaire is designed multi-dimensionally to assess the degree of recovery after anesthesia and surgery, and has been validated in previous studies. The present study aims to compare the quality of recovery with the QoR-40 questionnaire, in patients undergoing correctional tibial osteotomy under general anesthesia with either TIVA with propofol or inhalational anesthesia with desflurane.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Inhalational versus intravenous maintenance of anesthesia for quality of recovery in patients undergoing corrective lower limb osteotomy: A randomized controlled trial.
Kim SH, Ju HM, Choi CH, Park HR, et al · · 2021 · cited 6× · PMID 33606764 · DOI 10.1371/journal.pone.0247089

Verify or expand the search:

Other trials of propofol and remifentanil

Trials testing the same drug.

NCT06524596 — Study on Gynecological Laparoscopy Under Total Intravenous Anesthesia · NA · completed
NCT03539003 — The Comparison of Changes of QTc, Tp-e Interval, and Tp-e/QT Ratio, Tp-e/QTc Ratio on the ECG During Robotic-assisted La · NA · completed
NCT04333992 — Propofol Versus Sevoflurane on Acute Postoperative Pain · NA · completed

Other recruiting trials for Short Stature

Currently open trials in the same condition.

NCT04219007 — Vosoritide for Selected Genetic Causes of Short Stature · Phase 2 · active not recruiting

Other Yonsei University trials

Trials by the same sponsor.

NCT07547592 — Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma · Phase 2 · not yet recruiting
NCT07524101 — Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD · NA · not yet recruiting
NCT07506629 — Adductor Canal Block Methods in Bilateral Total Knee Arthroplasty · NA · not yet recruiting
NCT07515716 — Effects of High Flow Humidified Oxygen on Umbilical Artery Acid-base Balance in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07507188 — Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02826902 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yonsei University
Last refreshed: 16 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02826902.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing